Using online tools to improve patient involvement in cancer trials
Pilot Study on the Use of iENTER, iCONSENT and iPARTICIPATE E-tools
This study is testing new online tools to help cancer patients get involved in clinical trials and make informed decisions about their treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Academic / other |
| Locations | 1 site (Milano) |
| Trial ID | NCT06317961 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on enhancing patient engagement in precision oncology through the development of three interconnected web-based tools: iENTER, iCONSENT, and iPARTICIPATE. These tools aim to provide information, facilitate the informed consent process, and promote active participation in the Basket of Basket (BoB) trial for cancer patients. By leveraging technology, the study seeks to improve the efficiency of patient recruitment and adherence to clinical trials, ultimately contributing to more personalized cancer treatment approaches.
Who should consider this trial
Good fit: Ideal candidates for this study are cancer patients or their informal caregivers who are eligible for precision oncology trials and are comfortable using the internet.
Not a fit: Patients with clinically evident cognitive impairment may not benefit from this study due to the reliance on online tools for participation.
Why it matters
Potential benefit: If successful, this initiative could significantly enhance patient involvement and streamline the process of participating in precision oncology trials.
How similar studies have performed: While the use of digital tools in clinical trials is gaining traction, this specific approach within the context of precision oncology is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cancer patients, or their informal caregivers, candidates to precision oncology trials. Patients or caregivers able to surf the internet and to fill in a simple online form. Exclusion Criteria: * People with clinically evident cognitive impairment.
Where this trial is running
Milano
- Fondazione IRCCS Istituto Nazionale dei Tumori — Milano, Italy (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.